"Phenylacetates" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Derivatives of phenylacetic acid. Included under this heading are a variety of acid forms, salts, esters, and amides that contain the benzeneacetic acid structure. Note that this class of compounds should not be confused with derivatives of phenyl acetate, which contain the PHENOL ester of ACETIC ACID.
| Descriptor ID |
D010648
|
| MeSH Number(s) |
D02.241.223.601
|
| Concept/Terms |
Phenylacetic Acids- Phenylacetic Acids
- Acids, Phenylacetic
- Benzeneacetic Acids
- Acids, Benzeneacetic
|
Below are MeSH descriptors whose meaning is more general than "Phenylacetates".
Below are MeSH descriptors whose meaning is more specific than "Phenylacetates".
This graph shows the total number of publications written about "Phenylacetates" by people in this website by year, and whether "Phenylacetates" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 |
| 2001 | 1 | 0 | 1 |
| 2002 | 1 | 0 | 1 |
| 2003 | 1 | 0 | 1 |
| 2004 | 1 | 1 | 2 |
| 2006 | 0 | 1 | 1 |
| 2008 | 1 | 0 | 1 |
| 2012 | 1 | 1 | 2 |
| 2013 | 1 | 0 | 1 |
| 2014 | 0 | 1 | 1 |
| 2015 | 0 | 1 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 2 | 0 | 2 |
| 2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Phenylacetates" by people in Profiles.
-
Association Between Change in Ambulatory Hemodynamic Pressures and Symptoms of Heart Failure. Circ Heart Fail. 2021 11; 14(11):e008446.
-
Prenatal treatment of ornithine transcarbamylase deficiency. Mol Genet Metab. 2018 03; 123(3):297-300.
-
Quantitation of phenylbutyrate metabolites by UPLC-MS/MS demonstrates inverse correlation of phenylacetate:phenylacetylglutamine ratio with plasma glutamine levels. Mol Genet Metab. 2017 11; 122(3):39-45.
-
Nepafenac 0.3% after Cataract Surgery in Patients with Diabetic Retinopathy: Results of 2 Randomized Phase 3 Studies. Ophthalmology. 2017 06; 124(6):776-785.
-
Possible Phenylacetate Hepatotoxicity During 4-Phenylbutyrate Therapy of Byler Disease. J Pediatr Gastroenterol Nutr. 2016 Mar; 62(3):424-8.
-
Treating inflammation after lens surgery. J Cataract Refract Surg. 2015 Oct; 41(10):2035.
-
Stress hormone exposure reduces mGluR5 expression in the nucleus accumbens: functional implications for interoceptive sensitivity to alcohol. Neuropsychopharmacology. 2014 Sep; 39(10):2376-86.
-
Elevated phenylacetic acid levels do not correlate with adverse events in patients with urea cycle disorders or hepatic encephalopathy and can be predicted based on the plasma PAA to PAGN ratio. Mol Genet Metab. 2013 Dec; 110(4):446-53.
-
Urinary phenylacetylglutamine as dosing biomarker for patients with urea cycle disorders. Mol Genet Metab. 2012 Nov; 107(3):308-14.
-
30-year follow-up of a patient with classic citrullinemia. Mol Genet Metab. 2012 Jun; 106(2):248-50.